Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
13.49
Dollar change
+0.51
Percentage change
3.93
%
IndexRUT P/E- EPS (ttm)-7.54 Insider Own18.31% Shs Outstand59.97M Perf Week12.14%
Market Cap809.00M Forward P/E- EPS next Y-2.48 Insider Trans0.94% Shs Float48.99M Perf Month-14.08%
Income-232.03M PEG- EPS next Q-0.37 Inst Own60.23% Short Float22.94% Perf Quarter-35.82%
Sales12.68M P/S63.80 EPS this Y33.43% Inst Trans-0.12% Short Ratio11.03 Perf Half Y12.42%
Book/sh4.78 P/B2.82 EPS next Y30.67% ROA-126.15% Short Interest11.24M Perf Year61.36%
Cash/sh5.16 P/C2.61 EPS next 5Y- ROE-154.98% 52W Range6.13 - 30.96 Perf YTD26.07%
Dividend Est.- P/FCF- EPS past 5Y-48.48% ROI-80.91% 52W High-56.42% Beta1.79
Dividend TTM- Quick Ratio10.18 Sales past 5Y0.00% Gross Margin93.35% 52W Low120.07% ATR (14)0.82
Dividend Ex-Date- Current Ratio10.18 EPS Y/Y TTM-203.81% Oper. Margin-1871.47% RSI (14)52.94 Volatility5.67% 6.58%
Employees55 Debt/Eq0.01 Sales Y/Y TTM436.51% Profit Margin-1829.44% Recom1.00 Target Price31.40
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-616.75% Payout- Rel Volume0.56 Prev Close12.98
Sales Surprise-63.25% EPS Surprise-269.12% Sales Q/Q-56.47% EarningsMay 14 BMO Avg Volume1.02M Price13.49
SMA205.49% SMA50-3.89% SMA200-6.43% Trades Volume571,751 Change3.93%
Date Action Analyst Rating Change Price Target Change
May-31-24Initiated Piper Sandler Overweight $27
Apr-30-24Initiated JP Morgan Overweight $24
Apr-15-24Initiated Guggenheim Buy $35
Jan-29-24Initiated Leerink Partners Outperform $30
Dec-19-23Initiated Wedbush Outperform $12
Oct-29-21Initiated Cantor Fitzgerald Overweight $35
Jul-09-24 07:00AM
Jun-27-24 08:00AM
May-22-24 02:05PM
May-21-24 07:01PM
May-20-24 11:14AM
08:00AM Loading…
08:00AM
May-17-24 08:51AM
08:00AM
May-14-24 01:54PM
09:10AM
08:00AM
May-08-24 08:00AM
May-02-24 08:00AM
Apr-30-24 07:29AM
Apr-26-24 10:00AM
08:26AM Loading…
Apr-25-24 08:26AM
Apr-05-24 08:00AM
Mar-28-24 11:53PM
04:02PM
Mar-26-24 08:00AM
08:00AM
Mar-18-24 05:44AM
Mar-07-24 08:00AM
Mar-04-24 07:00AM
Mar-01-24 08:00AM
Feb-20-24 08:15AM
08:00AM
Feb-16-24 04:05PM
Feb-13-24 10:38PM
04:05PM
08:34AM Loading…
Feb-07-24 08:34AM
Feb-06-24 09:20AM
08:00AM
Feb-05-24 08:00AM
Jan-08-24 07:00AM
Jan-04-24 08:00AM
Jan-03-24 08:00AM
Jan-02-24 08:00AM
Dec-26-23 08:30AM
08:30AM
Nov-10-23 08:00AM
Nov-09-23 08:00AM
Nov-08-23 08:00AM
Oct-23-23 02:50AM
Oct-19-23 08:00AM
Oct-04-23 11:00PM
Oct-03-23 08:00AM
Aug-17-23 08:19PM
Aug-09-23 08:00AM
Jun-30-23 09:51AM
Jun-29-23 09:00AM
Jun-02-23 07:55AM
May-23-23 04:05PM
May-09-23 08:50AM
May-05-23 08:00AM
Apr-20-23 08:50AM
Mar-16-23 08:00AM
Mar-13-23 07:32AM
Mar-09-23 08:45AM
Feb-08-23 08:00AM
Jan-31-23 06:52AM
Jan-06-23 04:05PM
02:46PM
10:35AM
08:00AM
Nov-14-22 08:00AM
Nov-09-22 12:00PM
Oct-04-22 06:08AM
Aug-24-22 06:59AM
Aug-23-22 09:00AM
Aug-05-22 08:00AM
Jul-06-22 09:28AM
08:00AM
Jun-09-22 08:00AM
Jun-02-22 08:00AM
May-26-22 08:07AM
May-23-22 08:00AM
May-19-22 03:27PM
11:31AM
08:00AM
May-12-22 08:00AM
Mar-28-22 08:00AM
Mar-17-22 06:40AM
Mar-14-22 12:30PM
Mar-11-22 10:48AM
08:00AM
Feb-08-22 03:00PM
10:22AM
08:00AM
Jan-11-22 09:56AM
06:46AM
Jan-10-22 04:15PM
Dec-17-21 07:11AM
Dec-07-21 07:00AM
Dec-01-21 01:12PM
07:00AM
Nov-29-21 07:00AM
Nov-15-21 05:00PM
Nov-09-21 04:05PM
Oct-20-21 08:00AM
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SIEGALL CLAY BPresident and CEOMay 21 '24Buy13.7820,434281,548419,636May 21 04:13 PM
BIENAIME JEAN JACQUESDirectorMay 21 '24Buy13.572,00027,1409,615May 22 04:49 PM
SIEGALL CLAY BPresident and CEOMay 20 '24Buy13.9179,5661,106,524399,202May 21 04:13 PM
SIEGALL CLAY BPresident and CEOOct 02 '23Buy5.91169,204999,996319,636Oct 04 05:35 PM
Turner BruceChief Strategy OfficerOct 02 '23Buy5.9142,300249,99342,300Oct 04 05:32 PM